Medical Oncology

, Volume 15, Issue 4, pp 203–211 | Cite as

Oligoclonal T cells in human cancer

  • Eva Halapi


Many solid tumors are characterised by the infiltration of lymphocytes and their presence has been correlated with a more favourable prognosis. These tumor-infiltrating lymphocytes (TIL), have been shown to possess specific cytolytic reactivity towards autologous tumours, thus suggesting that tumour cells may express antigens capable of eliciting an immune response. Expression of such tumour-associated antigens (TAA) in combination with appropriate accessory signals would lead to thein vivo accumulation of T cells with anti-tumour specificity. Analysis of the composition of the specific T-cell receptor (TCR) of TIL could thus provide information on the nature of the antigen(s) recognised by TIL. In this review, different aspects of the presence of clonal T cells in patients with cancer are discussed.


tumor-infiltrating lymphocytes T cell receptor tumor-associated antigen melanoma multiple myeloma idiotype 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Danska JS, Livingstone AM, Paragas V, Ishihara T, Fathman CG. The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.J Exp Med 1990;172: 27–33.PubMedCrossRefGoogle Scholar
  2. 2.
    Garboszi DNet al. Structure of the complex between human T-cell receptor viral peptide and HLA-A2.Nature 1996;384: 134–141.CrossRefGoogle Scholar
  3. 3.
    Garcia KCet al. An alpha-beta receptor T cell receptor structure 2.5 A and its orientation in the TCR-MHC complex.Science 1996;274: 209–219.PubMedCrossRefGoogle Scholar
  4. 4.
    Shaw AS, Dustin ML. Making the T cell receptor go the distance: a topological view of T cell activation.Immunity 1997;6: 361–369.PubMedCrossRefGoogle Scholar
  5. 5.
    Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors.Cell 1994;76: 263–274.PubMedCrossRefGoogle Scholar
  6. 6.
    Chan AC, Iwashima M, Turck CW, Weiss A. Zap-70: a 70 Kd protein-tyrosine kinase that associates with the TCR zeta chain.Cell 1992;71: 649–662.PubMedCrossRefGoogle Scholar
  7. 7.
    June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families.Immunol Today 1994;15: 321–331.PubMedCrossRefGoogle Scholar
  8. 8.
    Shaw ASet al. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the aminoterminal domain of the p56lck tyrosine protein kinase.Mol Cell Biol 1990;10: 1853–1862.PubMedGoogle Scholar
  9. 9.
    Baccala R, Kono DH, Walker S, Balderas RS, Theofilopoulos AN. Genomically imposed and somatically modified human thymocyte V beta gene repertoires.Proc Natl Acad Sci USA 1991;88: 2908–2912.PubMedCrossRefGoogle Scholar
  10. 10.
    Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus.Science 1996;272: 1755–1762.PubMedCrossRefGoogle Scholar
  11. 11.
    Grunewald J, Janson CH, Wigzell H. Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes.Eur J Immunol 1991;21: 819–822.PubMedCrossRefGoogle Scholar
  12. 12.
    DerSimonian H, Band H, Brenner MB. Increased frequency of T cell receptor V alpha 12.1 expression on CD8+ T cells: evidence that V alpha participates in shaping the peripheral T-cell repertoire.J Exp Med 1991;174: 639–648.PubMedCrossRefGoogle Scholar
  13. 13.
    Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor variable gene segment families.Immunogenetics 1995;42: 455–500.PubMedGoogle Scholar
  14. 14.
    Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition.Nature 1988;334: 395.PubMedCrossRefGoogle Scholar
  15. 15.
    Pullen AM, Marrack P, Kappler JW. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.Nature 1988;335: 796–801.PubMedCrossRefGoogle Scholar
  16. 16.
    Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease.Proc Soc Exp Biol Med 1996;212: 99–109.PubMedGoogle Scholar
  17. 17.
    Choi Yet al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.J Exp Med 1990;172: 981–984.PubMedCrossRefGoogle Scholar
  18. 18.
    Gulwani-Akolkar B, Akolkar PN, Gregersen PK, Silver J. Analysis of the peripheral blood T-cell receptor repertoire in monozygotic twins discordant for rheumatoid arthritis.Ann N Y Acad Sci 1995;756: 176–178.PubMedCrossRefGoogle Scholar
  19. 19.
    Loveridge JA, Rosenberg WM, Kirkwood TB, Bell JI. The genetic contribution to human T-cell receptor repertoire.Immunology 1991;74: 246–250.PubMedGoogle Scholar
  20. 20.
    Raaphorst FMet al. Usage of TCRAV and TCRBV gene families in human fetal and adult TCR rearrangements.Immunogenetics 1994;39: 343–350.PubMedCrossRefGoogle Scholar
  21. 21.
    Schwab Ret al. Expanded CD4+ and CD8+ T cell clones in elderly humans.J Immunol 1997;158: 4493–4499.PubMedGoogle Scholar
  22. 22.
    Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples.Immunol Today 1995;16: 176–181.PubMedCrossRefGoogle Scholar
  23. 23.
    Kayser C, Waase I, Weyand CM, Goronzy JJ. T cell receptor germline gene segments and HLA haplotypes control the length of the CDR3 of human T cell receptor beta chains.Cell Immunol 1996;168: 235–242.PubMedCrossRefGoogle Scholar
  24. 24.
    Akolkar PN, Gulwani-Akolkar B, McKinley M, Fisher SE, Silver J. Comparisons of T cell receptor (TCR) V beta repertoires of lamina propria and peripheral blood lymphocytes with respect to frequency and oligoclonality.Clin Immunol Immunopathol 1995;76: 155–163.PubMedCrossRefGoogle Scholar
  25. 25.
    Dunn DAet al. T-cell receptor V beta expression in normal human skin.Proc Natl Acad Sci USA 1993;90: 1267–1271.PubMedCrossRefGoogle Scholar
  26. 26.
    Gross GGet al. Distribution of dominant T cell receptor beta chains in human intestinal mucosa.J Exp Med 1994;180: 1337–1344.PubMedCrossRefGoogle Scholar
  27. 27.
    Ahangari Get al. RT-PCR based analysis of T-cell receptor B variable region gene usage in normal human breast skin resident T lymphocytes.Scand J Immunol 1996;44: 330–334.PubMedCrossRefGoogle Scholar
  28. 28.
    Alam Aet al. Persistence of dominant T cell clones in synovial tissues during rheumatoic arthritis.J Immunol 1996;156: 3480–3485.PubMedGoogle Scholar
  29. 29.
    Bender Aet al. T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells.J Exp Med 1995;181: 1863–1868.PubMedCrossRefGoogle Scholar
  30. 30.
    Gulwani-Akolkar Bet al. Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.J Clin Invest 1996;98: 1344–1354.PubMedGoogle Scholar
  31. 31.
    Paliard Xet al. Evidence for the effects of a superantigen in Rheumatoid arthritis.Science 1991;253: 325–329.PubMedCrossRefGoogle Scholar
  32. 32.
    Callan MFet al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.Nature Med 1996;2: 906–911.PubMedCrossRefGoogle Scholar
  33. 33.
    Pantaleo Get al. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.Nature 1994;370: 463–467.PubMedCrossRefGoogle Scholar
  34. 34.
    Monteiro Jet al. Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases.Mol Med 1995;1: 612–624.Google Scholar
  35. 35.
    Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to ‘benign monoclonal gammapathy’.J Exp Med 1994;179: 609–618.PubMedCrossRefGoogle Scholar
  36. 36.
    Hingorani Ret al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients.J Immunol 1996;156: 852–858.PubMedGoogle Scholar
  37. 37.
    Burrows SRet al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.J Exp Med 1995;182: 1703–1715.PubMedCrossRefGoogle Scholar
  38. 38.
    Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.Cell 1995;80: 695–705.PubMedCrossRefGoogle Scholar
  39. 39.
    Secarz EEet al. Dominance and crypticity of T cell antigenic determinants.Annu Rev Immunol 1993;11: 729–766.CrossRefGoogle Scholar
  40. 40.
    Koopmann JO, Hämmerling GJ, Momburg F. Generation, intracellular transport and loading of peptides associated with MHC class I molecules.Curr Opin Immunol 1997;9: 80–88.PubMedCrossRefGoogle Scholar
  41. 41.
    Hedrick SMet al. Selection of amino acid sequences in the beta chain of the T cell antigen receptor.Science 1988;239: 1541–1544.PubMedCrossRefGoogle Scholar
  42. 42.
    MacDonald HR, Casanova JL, Maryanski JL, Cerottini JC. Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune responsein vivo: direct monitoring by flow cytometry and polymerase chain reaction.J Exp Med 1993;177: 1487–1492.PubMedCrossRefGoogle Scholar
  43. 43.
    McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cellsin vivo.Science 1995;268: 106–111.PubMedCrossRefGoogle Scholar
  44. 44.
    Argaet VPet al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.J Exp Med 1994;180: 2335–2340.PubMedCrossRefGoogle Scholar
  45. 45.
    Kuwana M, Medsger Jr TA, Wright TM. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.J Immunol 1997;158: 485–491.PubMedGoogle Scholar
  46. 46.
    Grunewald Jet al. Blood 1998; in press.Google Scholar
  47. 47.
    de Campos-Lima PO, Levitsky V, Imreh MP, Gavioli R, Masucci MG. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.J Exp Med 1997;186: 83–89.PubMedCrossRefGoogle Scholar
  48. 48.
    Gaudin Cet al. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.Cancer Res 1995;55: 685–690.PubMedGoogle Scholar
  49. 49.
    Mouri Tet al. T cell receptor V alpha and V beta gene usage by tumour-infiltrating lymphocytes in oral squamous cell carcinoma.Cancer Immunol Immunother 1996;43: 10–18.PubMedCrossRefGoogle Scholar
  50. 50.
    Puisieux Iet al. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification ofin situ clonal T-cell expansions.Int J Cancer 1996;66: 201–208.PubMedCrossRefGoogle Scholar
  51. 51.
    Puisieux Iet al. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.J Immunol 1994;153: 2807–2818.PubMedGoogle Scholar
  52. 52.
    thor Straten P, Scholler J, Hou-Jensen K, Zeuthen J. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.Int J Cancer 1994;56: 78–86.PubMedCrossRefGoogle Scholar
  53. 53.
    Valteau Det al. T-cell receptor repertoire in neuroblastoma patients.Cancer Res 1996;56: 362–369.PubMedGoogle Scholar
  54. 54.
    Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.Int J Cancer 1993;54: 383–390.PubMedCrossRefGoogle Scholar
  55. 55.
    Yamamoto Yet al. Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas.Cancer Immunol Immunother 1993;37: 163–168.PubMedCrossRefGoogle Scholar
  56. 56.
    Nitta T, Kiyoshi S, Okumura K, Steinmann L. Predominant expression of T cell receptor Vα7 in tumor infiltrating lymphocytes of uveal melanomas.Science 1990;249: 672–674PubMedCrossRefGoogle Scholar
  57. 57.
    Salvi Set al. Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas.Cancer Res 1995;55: 3374–3379.PubMedGoogle Scholar
  58. 58.
    Sensi Met al. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variableregion gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.Proc Natl Acad Sci USA 1995;92: 5674–5678.PubMedCrossRefGoogle Scholar
  59. 59.
    thor Straten P, Becker JC, Seremet T, Brocker EB, Zeuthen J. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.J Clin Invest 1996;98: 279–284.PubMedGoogle Scholar
  60. 60.
    Duncan SR, Elias DJ, Roglic M, Pekny KW, Theofilopoulos AN. T-cell receptor biases and clonal proliferations in blood and pleural effusions of patients with lung cancer.Hum Immunol 1997;53: 39–48.PubMedCrossRefGoogle Scholar
  61. 61.
    Ebato M, Nitta Y, Yagita H, Sato K, Okumura K. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.Eur J Immunol 1994;24: 2987–2992.PubMedCrossRefGoogle Scholar
  62. 62.
    Ferradini Let al. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence forin situ T cell clonal expansion.J Clin Invest 1993;91: 1183–1190.PubMedGoogle Scholar
  63. 63.
    Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.Cancer Res 1992;52: 5913–5920.PubMedGoogle Scholar
  64. 64.
    Velotti Fet al. Clonality of tumor-infiltrating lymphocytes in human urinary bladder carcinoma.J Immunother 1997;20: 470–478.PubMedCrossRefGoogle Scholar
  65. 65.
    Yamamoto Ket al. Accumulation of distinct T cell clonotypes in human solid tumors.J Immunol 1995;154: 1804–1809.PubMedGoogle Scholar
  66. 66.
    Caignard Aet al. In situ demonstration of renal-cell-carcinoma-specific T-cell clones.Int J Cancer 1996;66: 564–570.PubMedCrossRefGoogle Scholar
  67. 67.
    Stephens M, Lim K, Stephens P, Thomas DW, Lim SH. Molecular characterisation of tumour infiltrating lymphocytes in oral squamous cell carcinoma.Cancer Immunol Immunother 1998;46: 34–40.PubMedCrossRefGoogle Scholar
  68. 68.
    Yosino Iet al. Oligoclonal T lymphocytes infiltrating human lung cancer tissue.Int J Cancer 1991;47: 654–658.CrossRefGoogle Scholar
  69. 69.
    Mackensen Aet al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma.J Clin Invest 1994;93: 1397–1402.PubMedCrossRefGoogle Scholar
  70. 70.
    Birck Aet al. Analysis of T cell receptor AV and BV chain gene expression by infiltrating lymphocytes in spitz naevi and in halo naevi.Melanoma Res 1997;7: 49–57.PubMedCrossRefGoogle Scholar
  71. 71.
    Hishii Met al. In vivo accumulation of the same antimelanoma T cell clone in two different metastatic sites.Proc Natl Acad Sci USA 1997;94: 1378–1383.PubMedCrossRefGoogle Scholar
  72. 72.
    Kumar A, Farace F, Gaudin C, Triebel F. Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.J Clin Invest 1996;97: 1219–1226.PubMedGoogle Scholar
  73. 73.
    Österborg Aet al. Clonal CD8+ and CD52 T cells are induced in responding B cell lymphoma patients treated with Campath-1H(anti-CD52).Eur J Haematol 1997:58: 5–13.PubMedCrossRefGoogle Scholar
  74. 74.
    Sensi Met al. Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.J Clin Invest 1997;99: 710–717.PubMedGoogle Scholar
  75. 75.
    Sensi Met al. Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination.J Immunother 1998;21: 198–204.PubMedCrossRefGoogle Scholar
  76. 76.
    Garrido Fet al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.Immunol Today 1997;18: 89–95.PubMedCrossRefGoogle Scholar
  77. 77.
    Pawelec G, Zeuthen J, Kiessling R. Escape from host-antitumor immunity.Crit Rev Oncol 1997;8: 111–141.Google Scholar
  78. 78.
    Yi Q, Österborg A. Idiotype-specific T cells in myltiple myeloma: targets for an immunotherapeutic invention?Med Oncol 1996;13: 1–7.PubMedGoogle Scholar
  79. 79.
    Österborg Aet al. Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type, I, major histocompatibility complex restricted, CD8 and CD4-specific T-cell responses.Blood 1998;91: 2459–2466.PubMedGoogle Scholar
  80. 80.
    Yi Qet al. Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies.Blood 1995;86: 3043–3049.PubMedGoogle Scholar
  81. 81.
    Bergenbrant Set al. Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients.Br J Haematol 1996;92: 840–846.PubMedCrossRefGoogle Scholar
  82. 82.
    Hsu FJet al. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma. Long-term results of a clinical trial.Blood 1997;89: 3129–3135.PubMedGoogle Scholar
  83. 83.
    Brown RD, Yuen E, Nelson M, Gibson J, Joshua D. The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma.Leukemia 1997;11: 1312–1317.PubMedCrossRefGoogle Scholar
  84. 84.
    Halapi Eet al. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.Eur J Immunol 1997;27: 2245–2252.PubMedCrossRefGoogle Scholar
  85. 85.
    Moss P, Gillespie G, Frodsham P, Bell J, Reyburn H. Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia.Blood 1996;87: 3297–3306.PubMedGoogle Scholar
  86. 86.
    Farace Fet al. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiplein vivo T cell clonal expansions.J Immunol 1994;153: 4281–4290.PubMedGoogle Scholar
  87. 87.
    Serrano Det al. Clonal expansion within the CD4+ CD57+ and CD8+ CD57+ T cell subsets in chronic lymphocytic leukemia.J Immunol 1997;158: 1482–1489.PubMedGoogle Scholar
  88. 88.
    Kluin-Nelemans JCet al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia.Blood 1996;87: 3795–3802.PubMedGoogle Scholar
  89. 89.
    Van den Eynde BJ, van der Bruggen P. T cell defined tumor antigens.Curr Opin Immunol 1997;9: 684–693.PubMedCrossRefGoogle Scholar
  90. 90.
    Fisk Bet al. Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4 CTL lines.Scand J Immunol 1994;40: 591–600.PubMedCrossRefGoogle Scholar
  91. 91.
    Slamon DJet al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer.Science 1989;244: 707–712.PubMedCrossRefGoogle Scholar
  92. 92.
    Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.J Immunol 1993;151: 5472–5480.PubMedGoogle Scholar
  93. 93.
    Peoples GEet al. TCR V beta 3+ and V beta 6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers.J Immunol 1994;152: 4993–4999.PubMedGoogle Scholar
  94. 94.
    Yasumura Set al. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.Int J Cancer 1994;57: 297–305.PubMedCrossRefGoogle Scholar
  95. 95.
    Sensi Met al. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpressin vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.J Exp Med 1993;178: 1231–1246.PubMedCrossRefGoogle Scholar
  96. 96.
    Jantzer P, Schendel DJ. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and longterm persistencein vivo.Cancer Res 1998;58: 3078–3086.PubMedGoogle Scholar
  97. 97.
    Leong SPet al. T cell receptor usage by cytotoxic T lymphocytes against autologous human melanoma.Anticancer Res 1996;16: 3355–3361.PubMedGoogle Scholar
  98. 98.
    Nishimura MIet al. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.J Immunother 1994;16: 85–94.CrossRefGoogle Scholar
  99. 99.
    Heike Met al. Dominant TCRB-V-J chain usage and clonal expansion of sarcoma-reactive CD4+ HLA-DR-restricted T cells suggests a limited set of immunodominant sarcoma antigens.Int J Cancer 1997;72: 403–407.PubMedCrossRefGoogle Scholar
  100. 100.
    Romero Pet al. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted melan-A/MART-1 antigenic peptide in melanoma.J Immunol 1997;159: 2366–2374.PubMedGoogle Scholar
  101. 101.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.Cancer Res 1997;57: 5320–5327.PubMedGoogle Scholar
  102. 102.
    Romero Pet al. Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1.J. Exp Med 1995;182: 1019–1028.PubMedCrossRefGoogle Scholar
  103. 103.
    Visseren MJet al. Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generatedin vitro against a single tyrosinase epitope.Int J Cancer 1997;72: 1122–1128.PubMedCrossRefGoogle Scholar
  104. 104.
    Farina C, van der Bruggen P, Boel P, Parmiani G, Sensi M. Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens.Int Immunol 1996;8: 1463–1466.PubMedCrossRefGoogle Scholar

Copyright information

© Stockton Press 1998

Authors and Affiliations

  1. 1.deCODE Genetics Inc.ReykjavikIceland

Personalised recommendations